« Back
Home /
Amuvatinib

Amuvatinib

Manufacturer	TargetMol
Category	Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Amount	50mg
Item no.	TMO-T2516-50mg
Targets	FLT3, KIT
CASRN	850879-09-3
eClass 6.1	32169090
eClass 9.0	32169090
Available
Short Description	Amuvatinib is an orally bioavailable synthetic carbothioamide with potential antineoplastic activity.
Shipping	cool pack
Storage	-20°
Target names or alias	HPK 56 , MP470
Molecular Weight	447, 51
Pathway	Cell Cycle/Checkpoint\|\|\|DNA Damage/DNA Repair\|\|\|Angiogenesis\|\|\|Tyrosine Kinase/Adaptors\|\|\|Apoptosis
Target	c-RET\|\|\|DNA/RNA Synthesis\|\|\|PDGFR\|\|\|FLT\|\|\|c-Met/HGFR\|\|\|c-Kit\|\|\|Apoptosis

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 50mg

available

Delivery expected until 5/23/2024